Wulf Hans Christian, Wiegell Stine Regin
Department of Dermatology, Bispebjerg University Hospital, Copenhagen, Denmark.
JAMA Dermatol. 2022 Mar 1;158(3):283-287. doi: 10.1001/jamadermatol.2021.5491.
Hailey-Hailey disease (HHD) is a chronic genodermatosis with recurrent vesicles and erosions mainly in the intertriginous areas. Hailey-Hailey disease severely affects patient quality of life. Standard treatments attempt to control the flares, but often do not result in long-term remission of the disease.
To describe outcomes of treatment with superficial radiotherapy (SR) for severe treatment-refractory HHD.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective case-series included 13 patients with severe HHD with a mean (SD) duration of 24 (14) years whose treatments with SR and follow-up were conducted at the Department of Dermatology at Bispebjerg University Hospital (Copenhagen, Denmark) from January 2015 to April 2021.
Patients were treated with SR (20 kilovolt; 8 fractions of 2 gray was equal to 1 cycle) with a total dose of 16 gray in each treatment cycle. Patients received 1 to 6 treatment cycles with 1 to 5 separate body areas treated in each cycle. Sixty-two separate body areas were treated with SR.
Complete long-term remission, defined as no relapse during follow-up of at least 12 months.
For the 13 participants (mean [SD] age, 52 [18] years; 8 women [62%]), 56 of 62 treated areas (90%) achieved long-term remission, and the mean (SD) follow-up was 32 (12) months for the successfully treated areas. Nine of 13 patients (69%) responded with complete remission of all treated areas after the first treatment cycle and an additional 3 patients experienced complete remission after the second SR cycle. One patient with partial remission in 1 of 2 treated skin areas experienced such an improvement in HHD that they chose to abstain from retreatment. The treatment was followed by severe inflammation lasting for up to 1 month followed by temporary slight hyperpigmentation of the treated areas. The average Dermatology Life Quality Index score before treatment with SR was 22 (the disease having extremely large effect on the patient's life) and decreased to an average of 3 (small effect on the patient's life) after treatment with SR.
The results of this case series suggest that treatment with SR was associated with remission in patients with severe HHD and may provide a long-term improvement of treated skin areas.
黑利-黑利病(HHD)是一种慢性遗传性皮肤病,主要在皮肤褶皱部位反复出现水疱和糜烂。黑利-黑利病严重影响患者生活质量。标准治疗试图控制病情发作,但往往无法使疾病长期缓解。
描述浅表放射治疗(SR)对严重难治性HHD的治疗效果。
设计、背景和参与者:本回顾性病例系列研究纳入了13例严重HHD患者,平均(标准差)病程为24(14)年,于2015年1月至2021年4月在比斯佩比约格大学医院(丹麦哥本哈根)皮肤科接受SR治疗并进行随访。
患者接受SR治疗(20千伏;8次分割,每次2格雷等于1个疗程),每个治疗周期总剂量为16格雷。患者接受1至6个治疗周期,每个周期治疗1至5个不同身体部位。共对62个不同身体部位进行了SR治疗。
完全长期缓解,定义为在至少12个月的随访期内无复发。
对于13名参与者(平均[标准差]年龄为52[18]岁;8名女性[62%]),62个治疗部位中的56个(90%)实现了长期缓解,成功治疗部位的平均(标准差)随访时间为32(12)个月。13名患者中有9名(69%)在第一个治疗周期后所有治疗部位完全缓解,另外3名患者在第二个SR周期后完全缓解。1名患者在2个治疗皮肤部位中的1个部分缓解,其HHD病情有改善,因此选择不再接受治疗。治疗后出现严重炎症,持续长达1个月,随后治疗部位出现暂时轻微色素沉着。SR治疗前皮肤病生活质量指数平均评分为22(疾病对患者生活有极大影响),SR治疗后降至平均3分(对患者生活影响较小)。
本病例系列研究结果表明,SR治疗与严重HHD患者的病情缓解相关,可能使治疗的皮肤部位得到长期改善。